Nasal allergen test to start and track allergy shots
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study uses a nasal allergen “provocation” test to help decide how to start and monitor allergy immunotherapy (allergy shots or drops). It may help doctors better track whether the treatment is working for people with allergic rhinitis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re older than 18 but 60 or younger
- You have ongoing or recurring allergy symptoms in the nose (or doctors suspect “local” allergy in the nose)
- You must have allergy evidence from skin or blood testing (specific IgE)
- You are starting allergy immunotherapy (AIT) and can come to all study visits
- You can understand the study and sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This study checks how well a newer, detailed allergy test (using specific allergen components) can guide whether you should get allergy immunotherapy (allergy shots) for things like dust mites or grass pollen. It may help patients get the right treatment plan by improving how doctors confirm what allergens are driving symptoms.
This trial tests a new way to treat allergies by injecting allergy medicine directly into the tonsils. It may help people with hay fever who haven't gotten relief from standard treatments or want to avoid long-term medication.
This study uses a nasal allergen provocation test to help diagnose chronic rhinitis more accurately. If you have allergic rhinitis or are a healthy volunteer, you may help researchers learn how well this test works.
This trial collects information from people of all ages who have allergic rhinitis, conjunctivitis, or asthma and are prescribed allergy immunotherapy (shots or drops). The goal is to understand how these treatments work in real life.
This trial tests a new way of giving allergy shots directly into the tonsils to treat dust mite allergies that cause runny nose, sneezing, and itchy eyes. It aims to see if this method is safer and works better than standard treatment.
Hear when a new Perennial Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.